Tech Company M&A Transactions
Neuronex Acquisition
Neuronex was acquired by Acorda Therapeutics. The transaction was announced on 2/19/2012. Acorda Therapeutics said the transaction price was $133 million.
Transaction Overview
Company Name
Acquired By
Announced On
2/19/2012
Transaction Type
M&A
Amount
$133,000,000
M&A Terms
Under the terms of the Merger Agreement, after closing of the Merger, the former equity holders of Neuronex will be entitled to receive from Acorda up to an additional $18 million in earnout payments upon the achievement of specified regulatory and manufacturing-related milestones with respect to the DZNS product, and up to $105 million upon the achievement of specified sales milestones with respect to the DZNS product.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
9001 Aerial Center Parkway 110
Morrisville, NC 27560
USA
Morrisville, NC 27560
USA
Phone
Website
Email Address
Overview
Neuronex is a development stage pharmaceutical company focused on drugs that treat Central Nervous System (CNS) diseases and disorders. The company aims to combine clinical expertise with a thorough knowledge of the drug development process in a nimble, entrepreneurial environment, to achieve rapid success in obtaining approvals for our products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Moise Khayrallah
Chief Financial Officer
Karen Adams
Co-Founder
Gary Bream
VP - Operations
Stephen Butts
Browse more venture capital transactions:
Prev: 2/19/2012: NanoSolar venture capital transaction
Next: 2/20/2012: GoodRx venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs